Learning Objectives, March 2007

Printer-friendly version
Source: 
TCPR, March 2007, Vol 5, Issue 3, Antipsychotic Roundup 2007
Learning Objectives
Learning Objective NumberLearning Objective
Learning Objective Number: 
1
Learning Objective: 

Contrast the new antipsychotic Invega with Risperdal.

Learning Objective Number: 
2
Learning Objective: 

Outline the evidence for the antidepressant properties of
the second-generation antipsychotics.

Learning Objective Number: 
3
Learning Objective: 

Describe a rationale for deciding on a specific antipsychotic for a given patient.

This CME activity is intended for psychiatrists, psychiatric nurses, and other health-care professionals with an interest in the diagnosis and treatment
of psychiatric disorders.